Gut Microbiota and Alzheimer's Diseases
NCT03827733 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-04-19
Summary
The investigator will perform clinical studies to test a hypothesis that participants who have Alzheimer's disease will have different gut/oral microbiota profile as compared to the participants who do not have Alzheimer's disease. The investigators will also check the microbiome of their partners in this study. The investigators plan to perform the studies in 150 participants in Shanghai Tenth's People's Hospital and also in the houses in Shanghai city. Investigators will also measure the beta-amyloid in the feces of the participants. Finally, the investigators will determine cognitive function in these participants.
Conditions
- Alzheimer Disease
Sponsors & Collaborators
-
Shanghai 10th People's Hospital
lead OTHER
Principal Investigators
-
Yuan Shen, MD, PhD · Shanghai 10th People's Hospital
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
The Mechanism of MicroRNAs Network in Alzheimer's Disease
NCT05055310 ·Status: COMPLETED
-
Ageing Gut Brain Interactions
NCT03593941 ·Status: COMPLETED
-
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410 ·Status: RECRUITING
-
Synbiotic Formula (SCV09) in Alzheimer's Disease Patients
NCT06948929 ·Status: RECRUITING ·Phase: NA
-
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
NCT04804618 ·Status: RECRUITING
-
Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients
NCT06199193 ·Status: RECRUITING ·Phase: NA
-
Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
NCT00880347 ·Status: COMPLETED ·Phase: NA
-
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
NCT03089827 ·Status: ENROLLING_BY_INVITATION
-
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
NCT05943925 ·Status: UNKNOWN
-
Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients
NCT04094129 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Pathway for Alzheimer's Disease in China (CPAD)
NCT01779310 ·Status: COMPLETED
-
The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease
NCT01819545 ·Status: UNKNOWN
-
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
NCT07153848 ·Status: RECRUITING
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease
NCT03115814 ·Status: UNKNOWN
-
Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias
NCT06880406 ·Status: RECRUITING ·Phase: NA
-
Correlation of P-glycoprotein Polymorphisms With Microbial Metabolites in Patients With Alzheimer's Disease on Medication
NCT05532644 ·Status: UNKNOWN
-
Immunohistochemical Study of Neurodegenerative Diseases
NCT05518409 ·Status: UNKNOWN ·Phase: NA
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
NCT02931136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
NCT03810794 ·Status: RECRUITING ·Phase: NA
-
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
NCT06199037 ·Status: TERMINATED ·Phase: PHASE2
-
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease
NCT02800395 ·Status: RECRUITING ·Phase: NA
-
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
NCT05817643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study
NCT06868030 ·Status: NOT_YET_RECRUITING